ERBB2 and breast carcinoma: For instance, the most widely known molecular subtypes, such as the luminal A, luminal B, HER2, and basal-like (triple-negative) groups, have site-specific, cumulative metastatic incidence rates, demonstrating substantial differences in the distant metastatic behavior of and overall survival between breast cancer subtypes [10].